Deferoxamine
Jump to navigation
Jump to search
| Deferoxamine | |
|---|---|
| Term | Deferoxamine |
| Short definition | Deferasirox - (pronounced) (deh-FER-a-ser-ox) A drug used to treat excess iron in the blood caused by blood transfusions. It is being studied for the treatment of myelodysplastic syndromes (a group of diseases in which the bone marrow does not produce enough healthy blood cells) and other conditions. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
deferoxamine - (pronounced) (DEH-feh-ROK-suh-meen) An iron chelator that removes iron from tumors by inhibiting DNA synthesis and causing cancer cell death. It is used in conjunction with other anticancer drugs in the therapy of pediatric neuroblastoma
External links
- Medical encyclopedia article on Deferoxamine
- Wikipedia's article - Deferoxamine
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski